Literature DB >> 31847695

Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Selin Oncul1,2, Paola Amero1, Cristian Rodriguez-Aguayo1,3, George A Calin1,3, Anil K Sood4, Gabriel Lopez-Berestein1,3.   

Abstract

Long non-coding RNAs (lncRNAs), initially recognized as byproducts of the transcription process, have been proven to play crucial modulatory roles in preserving overall homoeostasis of cells and tissues. Furthermore, aberrant levels of these transcripts have been shown to contribute many diseases, including cancer. Among these, many aspects of ovarian cancer biology have been found to be regulated by lncRNAs, including cancer initiation, progression and dissemination. In this review, we summarize recent studies to highlight the various roles of lncRNAs in ovary in normal and pathological conditions, immune system, diagnosis, prognosis, and therapy. We address lncRNAs that have been extensively studied in ovarian cancer and their contribution to cellular dynamics.

Entities:  

Keywords:  Long non-coding RNA; biomarker; diagnosis; oncogene; ovarian cancer; therapeutics; tumour suppressor

Year:  2019        PMID: 31847695      PMCID: PMC7567512          DOI: 10.1080/15476286.2019.1702283

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  145 in total

1.  Prostate cancer: diagnostic performance of the PCA3 urine test.

Authors:  George Leighton Lee; Albert Dobi; Shiv Srivastava
Journal:  Nat Rev Urol       Date:  2011-03       Impact factor: 14.432

2.  Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Authors:  Kailiang Zhao; Yang Yang; Guang Zhang; Chenfeng Wang; Decai Wang; Mian Wu; Yide Mei
Journal:  EMBO Rep       Date:  2018-01-02       Impact factor: 8.807

3.  The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8.

Authors:  Dazun Shi; Yu Zhang; Rong Lu; Yi Zhang
Journal:  Biomed Pharmacother       Date:  2017-11-06       Impact factor: 6.529

4.  A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.

Authors:  Zhongping Cheng; Jing Guo; Li Chen; Ning Luo; Weihong Yang; Xiaoyan Qu
Journal:  Oncotarget       Date:  2015-09-22

5.  The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice.

Authors:  Shinichi Nakagawa; Masayuki Shimada; Kaori Yanaka; Mari Mito; Takashi Arai; Eiki Takahashi; Youko Fujita; Toshihiko Fujimori; Laura Standaert; Jean-Christophe Marine; Tetsuro Hirose
Journal:  Development       Date:  2014-10-30       Impact factor: 6.868

6.  Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.

Authors:  Aeyung Kim; Minju Im; Nam-Hui Yim; Jin Yeul Ma
Journal:  Sci Rep       Date:  2014-11-11       Impact factor: 4.379

7.  A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer.

Authors:  Ofer Lavie; David Edelman; Tally Levy; Ami Fishman; Ayala Hubert; Yakir Segev; Eli Raveh; Michal Gilon; Avraham Hochberg
Journal:  Arch Gynecol Obstet       Date:  2017-02-03       Impact factor: 2.344

8.  Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.

Authors:  Jun-Jun Qiu; Xiao-Jing Lin; Xiao-Yan Tang; Ting-Ting Zheng; Ying-Ying Lin; Ke-Qin Hua
Journal:  Int J Biol Sci       Date:  2018-11-01       Impact factor: 6.580

9.  NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.

Authors:  A R Özeş; D F Miller; O N Özeş; F Fang; Y Liu; D Matei; T Huang; K P Nephew
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

10.  Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer.

Authors:  Yue Gao; Xin Li; Hui Zhi; Yunpeng Zhang; Peng Wang; Yanxia Wang; Shipeng Shang; Ying Fang; Weitao Shen; Shangwei Ning; Steven Xi Chen; Xia Li
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-14       Impact factor: 8.886

View more
  9 in total

Review 1.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

2.  PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.

Authors:  Kevin Tabury; Mehri Monavarian; Eduardo Listik; Abigail K Shelton; Alex Seok Choi; Roel Quintens; Rebecca C Arend; Nadine Hempel; C Ryan Miller; Balázs Györrfy; Karthikeyan Mythreye
Journal:  Life Sci Alliance       Date:  2022-07-12

3.  Derivation and Validation of a Necroptosis-Related lncRNA Signature in Patients with Ovarian Cancer.

Authors:  Linling Zhu; Jiaoyan He; Xinyun Yang; Jianfeng Zheng; Wenhua Liu; Hao Chen
Journal:  J Oncol       Date:  2022-05-23       Impact factor: 4.501

Review 4.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

5.  PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.

Authors:  Abdelrahman M Elsayed; Emine Bayraktar; Paola Amero; Salama A Salama; Abdelaziz H Abdelaziz; Raed S Ismail; Xinna Zhang; Cristina Ivan; Anil K Sood; Gabriel Lopez-Berestein; Cristian Rodriguez-Aguayo
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

6.  Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.

Authors:  Zeyu Zhang; Zhijie Xu; Yuanliang Yan
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 7.  Role of different non-coding RNAs as ovarian cancer biomarkers.

Authors:  Anam Beg; Rafat Parveen; Hassan Fouad; M E Yahia; Azza S Hassanein
Journal:  J Ovarian Res       Date:  2022-06-17       Impact factor: 5.506

8.  MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription.

Authors:  Jun Tian; Lei Yang; Zhongtai Wang; Haiya Yan
Journal:  Aging (Albany NY)       Date:  2022-06-28       Impact factor: 5.955

9.  Mapping Intellectual Structure for the Long Non-Coding RNA in Hepatocellular Carcinoma Development Research.

Authors:  Zhifeng Lin; Xiaohui Ji; Nana Tian; Yu Gan; Li Ke
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.